Humanetics Corporation

Humanetics is a privately held, clinical stage pharmaceutical company located in the Minneapolis metropolitan area. Our lead candidate, BIO 300 is being developed for multiple clinical uses with a primary focus on improving treatment of solid tumor cancers. BIO 300 is being developed as an agent to both sensitize tumor cells to enhance radiation treatment efficacy and to protect normal tissues from harm. Thus, reducing common treatment related side effects such as radiation induced pneumonitis, erectile dysfunction, mucositis and xerostomia. BIO 300 is also under development for inflammatory lung diseases with an immediate focus on mitigation of pulmonary injury due...

Pharmaceuticals,oncology,medical countermeasures,biodefense,covid-19,inflammation,and radiation damage

Humanetics corporation operates in the Pharmaceutical manufacturing industry.

Humanetics corporation's revenue is 11m - 100m

Humanetics corporation has 11 - 50 employees.